Privilege escalation in Red Hat Build Of Keycloak
CVE-2026-9795
A flaw was found in Keycloak's Fine-Grained Admin Permissions (FGAPv2) feature. An administrator with limited client management permissions can exploit this vulnerability to assign any realm role, including highly privileged roles, to a client's scope mapping. This bypasses intended security controls, allowing the injected role to be projected into a user's authentication token when they access the modified client. This could lead to unauthorized privilege escalation within the Keycloak realm.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.3 (High). Vector: CVSS:3.1/AV:N/AC:H/PR:H/UI:R/S:C/C:H/I:H/A:N.
EPSS exploit prediction
EPSS: 0.005 (39.9th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 40th percentile — 39.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.004 · newest: 0.005 · change: +0.001
Affected products
- Red Hat Build Of Keycloak
- Red Hat Build Of Keycloak 26.4 — versions 26.4.13-1, 26.4-19
- Red Hat Build Of Keycloak 26.4.13
- Red Hat Build Of Keycloak 26.6 — versions 26.6-8, 26.6.4-2
- Red Hat Build Of Keycloak 26.6.4
- Red Hat Build Of Keycloak
Weakness classification (CWE)
References
- access.redhat.com/security/cve/CVE-2026-9795 (Mitigation, vdb-entry, Vendor Advisory)
- bugzilla.redhat.com/show_bug.cgi (issue-tracking, Issue Tracking, Vendor Advisory)
- access.redhat.com/errata/RHSA-2026:30083 (vendor-advisory)
- access.redhat.com/errata/RHSA-2026:30084 (vendor-advisory)
- access.redhat.com/errata/RHSA-2026:30049 (vendor-advisory)
- access.redhat.com/errata/RHSA-2026:30050 (vendor-advisory)
- 0b0ca135-0b70-47e7-9f44-1890c2a1c46c
Frequently asked questions
- What is CVE-2026-9795?
- CVE-2026-9795 is a high-severity vulnerability in Red Hat Build Of Keycloak, classified under Incorrect Privilege Assignment. CVSS score: 7.3/10. Published 2026-05-28.
- How severe is CVE-2026-9795?
- High severity. CVSS v3 base score is 7.3 out of 10.